Form 8-K - Current report:
SEC Accession No. 0002008861-25-000009
Filing Date
2025-05-07
Accepted
2025-05-07 07:09:42
Documents
15
Period of Report
2025-05-07
Items
Item 2.02: Results of Operations and Financial Condition
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K ndoi-20250507.htm   iXBRL 8-K 38485
2 EX-99.1 a20250331ex991earningsrele.htm EX-99.1 399655
6 image2a.jpg GRAPHIC 6108
  Complete submission text file 0002008861-25-000009.txt   594482

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT ndoi-20250507.xsd EX-101.SCH 1845
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT ndoi-20250507_lab.xml EX-101.LAB 19410
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT ndoi-20250507_pre.xml EX-101.PRE 11035
17 EXTRACTED XBRL INSTANCE DOCUMENT ndoi-20250507_htm.xml XML 2424
Mailing Address 9 GREAT VALLEY PARKWAY MALVERN PA 19355
Business Address 9 GREAT VALLEY PARKWAY MALVERN PA 19355 (484) 216-0000
Endo, Inc. (Filer) CIK: 0002008861 (see all company filings)

EIN.: 301390281 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 333-280767 | Film No.: 25919256
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)